Position in LH
as of Jun 30, 2026
· filed Aug 14, 2026
Position Value
$90,905,080
-$13,986,468 QoQ
Shares Held
324,661
-17.4% QoQ
Ownership
0.400%
of shares outstanding
% of Portfolio
0.14%
of 13F equity value
Holder Rank
#49
of 1,040 holders
Holding Since
Jun 2024
9 quarters on record
Voting authority
Sole 35%
Shared 0%
None 65%
Common Shares in LH Over Time
Shares Held
Position Value (USD)
Position in Diagnostics & Research
Healthcare · as of Jun 30, 2026LAZARD ASSET MANAGEMENT LLC holds $1,362,821,685 across 21 Diagnostics & Research names. LH ranks #4 (6.7% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | TMO |
Thermo Fisher Scientific Inc.
|
1,134,093 | $568,588,866 | |
| 2 | DHR |
Danaher Corp /De/
|
1,870,168 | $356,229,599 | |
| 3 | IQV |
Iqvia Holdings Inc.
|
975,420 | $188,470,652 | |
| 4 | LH |
Labcorp Holdings Inc.
This page
|
324,661 | $90,905,080 | |
| 5 | A |
Agilent Technologies, Inc.
|
641,892 | $85,262,513 | |
| 6 | DGX |
Quest Diagnostics Inc
|
94,528 | $20,035,209 | |
| 7 | IDXX |
Idexx Laboratories Inc /De
|
20,515 | $10,799,916 | |
| 8 | MEDP |
Medpace Holdings, Inc.
|
15,382 | $8,146,153 |
All Filings in LH
Export CSV
9 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $90,905,080 | 324,661 | Shares | Sole | 2026-08-14 | |
| 2026-03-31 | $104,891,548 | 393,132 | Shares | Sole | 2026-05-15 | |
| 2025-12-31 | $123,401,348 | 491,874 | Shares | Sole | 2026-02-17 | |
| 2025-09-30 | $138,799,250 | 483,520 | Shares | Sole | 2025-11-14 | |
| 2025-06-30 | $259,736,055 | 989,433 | Shares | Sole | 2025-08-14 | |
| 2025-03-31 | $71,050,865 | 305,280 | Shares | Sole | 2025-05-15 | |
| 2024-12-31 | $58,235,812 | 253,950 | Shares | Sole | 2025-02-14 | |
| 2024-09-30 | $49,975,713 | 223,625 | Shares | Sole | 2024-11-14 | |
| 2024-06-30 | $50,040,257 | 245,886 | Shares | Sole | 2024-08-14 | |
| No filing history on record for this holder in this stock. | ||||||